Levetiracetam (LEV) is a new antiepileptic drug, used in patients with partial and generalised epilepsy. The aim of this study is to evaluate the effect of LEV on background activity and EEG abnormalities in epileptic patients. We analysed S/EEG pre- and post- LEV onset of 41 epileptic patients. The quantitative analysis was performed on EEG of 10 randomly selected patients. EEGs were evaluated as unchanged in the 56%; improved in 37% and a worsened in 7%. Quantitative analysis of EEG only showed minimal decreasing of the absolute alpha band and an increasing of beta band (p <0.05).
|Translated title of the contribution||Effects of levetiracetam on the EEG: An inspective and quantitative study in epileptic patients|
|Number of pages||2|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - May 2008|
ASJC Scopus subject areas
- Clinical Neurology